New-onset type 2 diabetes was linked to an increased risk for developing certain cancers typically related to obesity, ...

New findings reveal a chilling link between type 2 diabetes and a hidden danger. The truth could change how we see both ...

Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year ...

A new study by UVA Health experts reveals that nearly 40% of type 2 diabetes patients stop their medication within a year.

GLP-1 RA use was associated with significantly lower risk of certain cancers compared with metformin use and insulin use.

The MOTIVATE-T2D trial demonstrated that wearables, including smartwatches, improved physical activity adherence in people ...

The following is a summary of “Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists,” ...

Glargine U300 use was common, especially with increased CKD stages and baseline HbA1c levels among patients with type 2 diabetes.

New research has investigated how a combination of dapagliflozin and moderate calorie restriction can cause remission in Type ...

Mounjaro is approved as an adjunct to a reduced-calorie diet and increased physical activity for adults with an initial body ...

Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year, diabetes experts warn.